Trial Profile
Bridging Study Using ch14.18/CHO Antibody in Children With Refractory Neuroblastoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Dinutuximab beta (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- 10 Nov 2012 New trial record